Inappropriate urination in feline medicine embraces the behavior of domestic cats to urinate for no specific reason in undesirable places for their guardians. Cats with behavioral problems are two to six times more likely to be abandoned and many animals are euthanized. The aim of this paper is to report a case of inappropriate urination in a domestic cat, from which a satisfactory response was observed in pharmacological treatment with fluoxetine hydrochlorid. A male domestic breed, male, sterilized at six months of age, four years old, was taken for clinical care. The tutor's complaint focused on the elimination of urine in undesirable places, such as dog’s bed, sofa. Through history and anamnesis, it was found that the feline at the time of the consultation had a strictly domiciled habit of living and that such behavior of Inappropriate urination had started after moving to a new apartment. The owner used to live in a larger home where cats had peridomiciliated habits. Clinical examination, laboratory tests (blood count and serum biochemistry), blood glucose, feline leukemia virus (FeLV) antigen and feline immunodeficiency virus (FIV) antibody testing and feline abdominal ultrasound did not result in changes. Noteworthy. Thus, through the diagnosis of elimination related to primary environmental / social factors, environmental enrichment measures were adopted that did not result in a satisfactory response. Consequently, the pharmacological therapy was prescribed with fluoxetine hydrochloride at a dose of 0.5 mg / kg orally every 24 hours until further recommendations. The animal presented improvement during the first 10 days after the start of drug treatment and 12 months after it remained without signs of periuria. There was no side effect associated with the therapy adopted. The factors that trigger the inappropriate elimination disorder are not necessarily those that maintain them, therefore justifying the non-response only to the environmental management adopted. Such a report may contribute to a better understanding and adoption of treatment techniques for inadvertent urination disorder in cats, which may help to reduce the tutor's dissatisfaction with felines that exhibit such behavior and consequently reduce the number of animals abandoned and euthanized because of this disorder.
Nasal sporotrichosis is a condition of difficult clinical resolution, which is commonly refractory to treatment and recurrent in cats. In this report, amphotericin B was used intralesionally in combination with oral itraconazole (100 mg/per cat/oral each 24h) in order to treat a cat with relapse of nasal sporotrichosis. During the treatment, laboratory tests were performed to ensure the safety of the protocol used. The new biomarker for renal function SDMA IDEXX was used before and after the end of the protocol to monitor renal function. Adverse effects were edema and local discomfort. Total treatment duration was 3 months, and no renal toxic effect was observed. This protocol therefore proved to be effective and safe to treat nasal sporotrichosis.
RELATO DE CASOCopyright Jardim et al. Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution Non-Commercial, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que sem fins comerciais e que o trabalho original seja corretamente citado.Osteocondrodisplasia em um felino jovem da raça Scottish Fold: relato de caso ResumoOs gatos Scottish Fold possuem um gene autossômico dominante que determina a ocorrência das orelhas dobradas para frente e graus variados de osteocondrodisplasia. Objetiva-se com este trabalho relatar um caso de osteocondrodisplasia em um gato jovem da raça Scottish Fold, destacando as características clínicas, patológicas e a conduta terapêutica adotada mediante o quadro clínico, visando difundir informações relacionadas ás particularidades deste padrão racial felino. Foi levado para atendimento clínico um gato doméstico da raça Scottish Fold, macho, com 12 meses de idade, devido à queixa de dificuldade locomotora. Na avaliação radiográfica as articulações társicas apresentaram-se hipoplásicas, com angulação anormal do eixo nos metatarsos, falanges e articulações relacionadas, compatível com osteocondrodisplasia. Já nas articulações coxofemorais evidenciou-se displasia coxofemoral leve. O tratamento consistiu na utilização de gabapentina, sulfato de condroitina e ômega-3. Este é o primeiro relato de osteocondrodisplasia em um Scottish Fold no Brasil. As deformidades osteoarticulares observadas no felino jovem da raça Scottish Fold com osteocondrodisplasia constituem uma preocupação, em função do comprometimento da qualidade de vida do paciente e ausência de um tratamento curativo para tal afecção, assim o estudo pôde expandir informações a respeito das características inerentes a este padrão racial.Palavras-chave: gatos, mutações genéticas, doenças osteoarticulares. AbstractScottish Fold cats have an autosomal dominant gene that determines the occurrence of forward-bent ears and varying degrees of osteochondrodysplasia. The objective of this work is to report a case of osteochondrodysplasia in a young Scottish Fold cat, highlighting the clinical and pathological characteristics and the therapeutic behavior adopted by the clinical picture, aiming to disseminate information related to the particularities of this feline racial pattern. A Scottish Fold male domestic cat, 12 months old, was brought to clinical care due to the complaint of locomotor difficulty. In the radiographic evaluation, the tarsal joints were hypoplastic, with abnormal axis angulation in the metatarsals, phalanges and related joints, compatible with osteochondrodysplasia. Already in the hip joints, mild hip dysplasia was evident. Treatment consisted of gabapentin, chondroitin sulfate and omega-3. This is the first report of osteochondrodysplasia in a Scottish Fold in Brazil. The osteoarticular deformities observed in the Scottish Fold feline with osteochondrodysplasia are a concern, due to the patient's quality of life impairment and the absence of a cura...
Background: Chylothorax in cats represents a challenge due to the possibility of involvement of multiple etiologies and the harmful consequences resulting of the presence of the chylous effusion in the thorax. The causes include neoplasms in the thoracic cavity, heart disease and thoracic injuries. It is imperative that clinical nutritional and therapeutic and / or surgical management be immediate and directed to the treatment of the cause. The objective of this work was to report a case of idiopathic chylothorax in a domestic cat solved through surgical intervention and dietary maintenance applied.Case: A 4-year-old male cat, fed with diet for the age range of adult cats, was attended at the Veterinary Hospital of the Federal Rural University of Rio de Janeiro (HV - UFRRJ), with clinical complaint of difficulty breathing, inappetence, prostration and weight loss. In the clinical examination was verified intense tachypnea, presence of heart murmur, normocoratedmucosae, dehydration 7%. The animal was sedated to be submitted to radiographic examination of the thorax with pethidine and midazolam. Thoracic radiographs on the lateral, ventral-dorsal and orthostatic positions were realized and severe pleural effusion was observed in both hemitorax with drainage of 180 mL of lactescent fluid from the right hemithorax and 120 mL of left hemithorax liquid. Through analysis of cavity liquids the effusion was classified as chylous effusion. The hemogram showed a neutrophilic leukocytosis. Serum cholesterol and triglyceride concentrations (28 mg/dL and 43 mg/dL, respectively) were lower than the concentrations of the cavity liquid (67 mg/dL and 722 mg/dL, respectively).Ultrasound examination revealed no mass in the thoracic cavity and no changes in the pulmonary parenchyma. The echocardiographic examination was also performed and did not reveal any cardiac alterations. The initial treatment consisted of the clinical approach, through the exclusive alimentary management with low fat diet, in order to reduce toreduce the amount of chylous in the thorax. The rutine was administered at a dose of 250 mg/cat every 8 h orally. After 15 days, due to an unsatisfactory response to conservative treatment, surgical intervention was indicated. The technique used was pleural omentalization with block ligation of the thoracic duct without mesenteric lymphangiography together with pericardectomy and placement of the thoracic drain. During the postoperative period the animal remained under intensive care, with nasal oxygen therapy and intense analgesia during the first 72 h. After 20 days, the production of the chylous liquid was 2 mL/kg/ day, which made it possible to remove the drain. The cat received continuously with the exclusive diet of low fat to reduce the production of the chylous, without recurrence of chylous up to the present moment.Discussion: It is important to establish in a first approach of animals with chylous exudation the management of low-fat foods, along with appropriate pharmacological therapy, monitoring the patient in a constant and cautious way. If conservative clinical intervention is not satisfactory within 5 to 10 days, rapid surgical treatment is essential, due to the risk offibrosing pleuritis with consequent involvement of the pulmonary parenchyma, as occurred in this report. Duct ligation surgery and the pericardectomy was satisfactory for the resolution of the constant chylous production in the thorax of the animal, as well as the use of the low fat diet was essential to reduce the chylous effusion and fibrosing pleurisy, both the interventions made possible the maintenance of the patient’s health and well-being.Keywords: feline, cavitary fluid, quilting effusion, thoracic duct.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.